Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 02, 2018

SELL
$102.37 - $117.25 $593,541 - $679,815
-5,798 Closed
0 $0
Q1 2018

Apr 25, 2018

SELL
$98.19 - $115.2 $94,753 - $111,168
-965 Reduced 14.27%
5,798 $619,000
Q4 2017

Jan 30, 2018

SELL
$100.43 - $118.09 $42,984 - $50,542
-428 Reduced 5.95%
6,763 $740,000
Q3 2017

Oct 30, 2017

BUY
$96.72 - $109.26 $695,513 - $785,688
7,191
7,191 $777,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wright Investors Service Inc Portfolio

Follow Wright Investors Service Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wright Investors Service Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wright Investors Service Inc with notifications on news.